References
- Pender ES, Pollack CV. Jr. Cough-variant asthma in children and adults: case reports and review. J Emerg Med 1990;8:727–731
- Antoniu SA, Mihaescu T, Donner CF. Pharmacotherapy of cough-variant asthma. Expert Opin Pharmacother 2007;8:3021–3028
- Lu Q. Clinical research coordination group of the causes constituents ratio of chronic cough in Chinese children. [Prospective multicenter clinical study on the causes constituents ratio of chronic cough in Chinese children]. Chin J Pediatr 2012;50:83–92
- Hong JG. Chronic cough and asthma in children: intensive reading of the Guideline for diagnosis and treatment of chronic cough in pediatrics (II). Zhonghua Er Ke Za Zhi 2008;46:819–821
- Niimi A, Matsumoto H, Minakuchi M, Kitaichi M, Amitani R. Airway remodelling in cough-variant asthma. Lancet 2000;356:564–565
- Matsumoto H, Niimi A, Takemura M, Ueda T, Tabuena R, Yamaguchi M, Matsuoka H, et al. Prognosis of cough variant asthma: a retrospective analysis. J Asthma 2006;43:131–135
- Fujimura M, Hara J, Myou S. Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough 2005;1:5
- Koh YY, Jeong JH, Park Y, Kim CK. Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness. Eur Respir J 1999;14:302–308
- Drugs@FDA - FDA Approved Drug Products. Budenoside. FDA. 2015. 12-12-2014. (Ref Type: Electronic Citation)
- Szefler SJ, Eigen H. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. J Allergy Clin Immunol 2002;109:730–742
- Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120:S94–S138
- Kohno S, Ishida T, Uchida Y, Kishimoto H, Sasaki H, Shioya T, Tokuyama K, et al. The Japanese Respiratory Society guidelines for management of cough. Respirology 2006;11:S135–S186
- Anderson WJ, Short PM, Williamson PA, Lipworth BJ. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENO-type trial. Chest 2012;142:1553–1561
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2006. Available from: www.ginasthma.org [last accessed 10 Aug 2015]
- Hong JG, Cheng HJ, Xie JJ, Yang JZ, Chen Q, He SR, Li Y, et al. A study of cough variant asthma treated with budesonide suspension nebulization in childhood. Chin J Pract Pediatr 2012;27:270–274
- Bao W, Chen Q, Lin Y, Liu H, Zhao G, Chen Z, Zhou X, et al. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma. Respirology 2013;18: 53–61
- Tagaya E, Kondo M, Kirishi S, Kawagoe M, Kubota N, Tamaoki J. Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma. J Asthma 2015;52:512–518
- Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143–178
- Pedersen SE, Hurd SS, Lemanske RF Jr., Becker A, Zar HJ, Sly PD, Soto-Quiroz M, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol 2011. doi: 10.1002/ppul.21321
- Liu M, Liu K, Zhu N, Xia J, Chen X. Inflammatory mediators in induced sputum and airway hyperresponsiveness in cough variant asthma during long-term inhaled corticosteroid treatment. Mediators Inflamm 2012;2012:403868
- Kamimura M, Izumi S, Hamamoto Y, Morita A, Toyota E, Kobayashi N, Kudo K, et al. Superiority of nebulized corticosteroids over dry powder inhalers in certain patients with cough variant asthma or cough-predominant asthma. Allergol Int 2012;61:411–417